NR1H4 and neoplasm: The mechanism by which FXR suppresses tumor growth remains unclear, but it may involve protecting the colonic epithelium from inflammation and ameliorating BA toxicity by upregulating intracellular BA-binding proteins and efflux transporters and downregulating influx transporters and de novo BA synthesis [35,36].